If a sample has been sent for follow-up testing, you can use the Unique ID code that you were given to find out the results here.

Call the New Zealand Drug Foundation if you want to anonymously talk through these results on (04) 801 6303, or email drugchecking@drugfoundation.org.nz

This page currently only has the results of follow-up testing at drug checking clinics run by the NZ Drug Foundation and the NZ Needle Exchange Programme.

 
There may be some delays with testing samples, so follow-up testing results may take a while to appear. Please check back if you can't find your sample on this page. Thanks for your patience.

Samples brought in during February

Substance presumed to be: Ketamine 

Date brought in for testing: 16th February, 2024 

Substances detected in the sample: Ketamine with no binder or filler 

Click here for more information on how to be safer when using Ketamine. 

Substance presumed to be: MDMA

Date brought in for testing: 16th February, 2024 

Substances detected in the sample: MDMA with no binder or filler 

Click here for more information on how to be safer when using MDMA. 

Samples brought in during January

Substance Presumed to be: MDMA

Date brought in for testing: January 16th, 2024 

Substances detected in the sample: 

Harm reduction information you want to include: (otherwise, as a standard we link them to the relevant drug info pages on the site). You may want to include the FTS result or other notes about testing here.

The result is consistent with a  Butylpentylone and Butylhexedrone mixture. These are both newly developed substituted cathinones that carry unpredictable effects. 

There is little information about the toxicity, effects, and abuse potential of these substances due to the novelty and extremely short history of human uses. Consumption of these particular substances has been associated with hospitalisations in Aotearoa. 

It is strongly advised not to take this sample. If choosing to consume, follow harm reduction practices such as not consuming alone, not redosing, and not consuming with other psychoactives. This sample is most similar to the Pentylone family

Substance presumed to be: Ketamine

Date brought in for testing: Middle of January

Substances detected in the sample: Ketamine

This sample was consistent with the presence of ketamine only.

Contact: Sample ID: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: Ketamine 

Date brought in for testing: First week of January

Substances detected in the sample: Methamphetamine, MDMA, Epsom salts

This sample was found to contain a combination of substances, including methamphetamine and MDMA. We are unable to determine how much of each drug was in this sample. Combining more than one stimulant is more stressful for your body, and creates greater risk of negative side effects and overdose.

If you choose to take this substance, we recommend having starting with a lower dose, having trusted folks around who can make sure you're well and safe, and limiting the maximum dose you might take. If you experience any concerning symptoms, call 111 immediately and seek medical support.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: Oxandrolone

Date brought in for testing: Middle of January

Substances detected in the sample: Oxandrolone

This sample was consistent with the steroid Oxandrolone. We are not able to determine the concentration or purity of the substance contained. If you choose to take this substance, we strongly recommend using good sterile technique to store and administer it.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

 

Samples brought in during December

Substance presumed to be: Methamphetamine or Aminorex

Date brought in for testing: 21st December, 2023 

Substances detected in the sample: The sample was sent for further lab analysis after initial testing was inconclusive. The sample was confirmed as levamisole or tetramisole, which are both chemically similar substances.

Levamisole is sometimes used as a binder in cocaine. It is also used to treat parasitic infections such as worms. In rare cases, levamisole can cause blood and skin conditions, especially in large amounts. If you feel unwell, or have lesions appear on your skin (especially cheeks and ears) seek medical help immediately.

Substance presumed to be: Unknown Sedative 

Date brought in for testing: 14th December, 2023 

Substances detected in the sample: Tapentadol, Lactose 

Tapentadol is a prescription opioid that is slightly weaker than morphine. It is recommended to use with a buddy and have naloxone on hand if possible. Lactose is a common binder in pharmaceutical drugs, that is relatively harmless, however do a nasal rinse after snorting, or ensure you use a filter to remove before injecting. 

Click here for more information on how to be safer when using prescription opioids. 

Substance presumed to be: Oxycodone 

Date brought in for testing: 14th December

Substances detected in the sample: Tramadol 

Tramadol is a prescription opioid that is weaker than morphine. Unlike some other opioids, tramadol affects the serotonin system, which means that when mixed with other drugs like SSRIs, MDMA or MAOIs, it can result in serotonin syndrome. It is recommended to use with a buddy and have naloxone available if possible .It is recommended that you still start with a small amount and wait at least an hour before taking more. Use with a sober buddy and have naloxone available. 

Click here for more information on how to be safer when using prescription opioids, like tramadol. 

Substance presumed to be: Methamphetamine

Date brought in for testing: 13th December, 2023 

Substances detected in the sample:  Methamphetamine, Pseudoephedrine and Dimethyl sulfone 

Dimethyl sulfone is a common non-psychoactive filler in many drugs. It is relatively harmless, but it is recommended to use a filter to remove before injecting, or do a nasal rinse after snorting as it can cause nasal discomfort. 

Click here for more information on how to be safer when using Methamphetamine and Prescription Stimulants.

 

Substance presumed to be: Etizolam

Date brought in for testing: 7th December, 2023 

Substances detected in the sample:  Etizolam and Cellulose (binder)

Cellulose is a common binder in pills. Remember, that the Etizolam may be distributed differently across the pill. It is best to crush, mix and measure before taking to achieve more even dosing. 

Click here for more information on how to be safer when using Benzos like etizolam. 

Substance presumed to be: Unknown benzo or opioid 

Date brought in for testing: 14th December, 2023 

Substances detected in the sample: Clonazepam 

Clonazepam is a benzo that is used medically for anxiety and seizures. It has a much faster onset than other benzos and is active in quite low doses. Avoid mixing with other depressant drugs as this increases your risk of overdose.

Click here for more information on how to be safer when using Benzos. 

Substance presumed to be: Alprazolam 

Date brought in for testing: 14th December, 2023 

Substances detected in the sample: Flubromazepam 

Flubromazepam is a benzodiazepine that is not used for medical purposes. It is long lasting and is active in quite low doses. Flubromazepam is much longer lasting than Alprazolam, so re-dosing is not recommended.  Avoid mixing any benzo with other depressant drugs as this increases your risk of overdose.

Click here for more information on how to be safer when using Benzos. 

Substance presumed to be: Methadone 

Date brought in for testing: 14th December, 2023 

Substances detected in the sample: Buprenorphine 

Buprenorphine is an opioid agonist that is often used for OST. It can still cause an opioid overdose, especially if you are taking in doses higher than prescribed, or injecting it. It is a good idea to use with a buddy and have naloxone available. Buprenorphine is active in much lower doses than methadone, so be cautious with dosing. 

Click here for more information on how to be safer when using Prescription Opioids. 

Substance presumed to be: Oxycodone 

Date brought in for testing: 14th December, 2023 

Substances detected in the sample: Oxycodone 

Is a opioid pain medicine that is 1.5-2x stronger than morphine. Oxycodone can be dangerous when mixed with DXM and Diphenhydramine. Your risk of overdose also increases when mixed with other depressants. It an come as instant release or extended release tablets- it is important to know which one you have so you know how long it will stay in your body. It is a good idea to use with a buddy, and have naloxone on hand.

Click here for more information on how to be safer when using Prescription Opioids. 

Substance presumed to be: Unknown benzo or opioid 

Date brought in for testing: 14th December, 2023 

Substances detected in the sample: Oxycodone 

Oxycodone is a opioid pain medicine that is 1.5-2x stronger than morphine. Oxycodone can be dangerous when mixed with DXM and Diphenhydramine. Your risk of overdose also increases when mixed with other depressants. It an come as instant release or extended release tablets- it is important to know which one you have so you know how long it will stay in your body. It is a good idea to use with a buddy, and have naloxone on hand.

Click here for more information on how to be safer when using Prescription Opioids. 

Substance presumed to be: Unknown

Date brought in for testing: 14th December, 2023 

Substances detected in the sample: Lorazepam

Lorazepam is a pharmaceutical benzo that is used to treat anxiety and sleeping disorders. It has a relatively long half-life and is active in low doses, so it is recommended to start with a small amount. It can increase your risk of overdose when combined with other depressants.

Click here for more information on how to be safer when using Benzos. 

Substance presumed to be: Alprazolam 

Date brought in for testing: 14th December, 2023 

Substances detected in the sample: Bromazolam 

Bromazolam is a novel benzo that is common in NZ. It has a very long half life, meaning it can take a while to kick in and stays in your body for a long time. Because of this, it is risky to use more bromazolam or other depressants up to 12 hours after you took your first dose. Bromazolam is also thought to be more potent than Alprazolam, so starting with a lower dose is recommended. 

Click here for more information on how to be safer when using Benzos. 

Substance presumed to be: Diazepam 

Date brought in for testing: 14th December, 2023 

Substances detected in the sample: Lorazepam 

Lorazepam is a pharmaceutical benzo that is used to treat anxiety and sleeping disorders. It has a relatively long half-life and is active in low doses, so it is recommended to start with a small amount. Lorazepam is also active in lower doses than Diazepam. You can use the Tripsit Benzo converter to compare dosing of these benzos. It can increase your risk of overdose when combined with other depressants.

Click here for more information on how to be safer when using Benzos. 

Substance presumed to be: Diazepam 

Date brought in for testing: 14th December, 2023 

Substances detected in the sample: Diazepam 

Click here for more information on how to be safer when using Benzos. 

Substance presumed to be: Methadone 

Date brought in for testing: 14th December, 2023 

Substances detected in the sample: Buprenorphine 

Buprenorphine is an opioid agonist that is often used for OST. It can still cause an opioid overdose, especially if you are taking in doses higher than prescribed, or injecting it. It is a good idea to use with a buddy and have naloxone available. Buprenorphine is active in much lower doses than methadone, so be cautious with dosing. 

Click here for more information on how to be safer when using Prescription Opioids. 

Substance presumed to be: Unknown 

Date brought in for testing: Middle of December

Substances detected in the sample: Cannabis (THC-A)

This sample was consistent with regular cannabis (THC-A containing flower) - no synthetic substances were detected.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: MDMA

Date brought in for testing: Middle of December

Substances detected in the sample: Dimethyl sulfone (MSM) - No psychoactive substance detected

No psychoactive substances were detected in this sample. Dimethyl sulfone is a dietary supplement which is generally considered safe for consumption by swallowing, but provides no psychoactive effect.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: MDMA

Date brought in for testing: Last week of December

Substances detected in the sample: Alpha-D2PV, Benzoin (Resin/gum-type substance)

This sample was substituted for alpha-D2PV - a high-risk synthetic cathinone (also known as bath salts). No MDMA was detected in this sample.

Alpha-D2PV may produce similar desirable effects as other stimulants, but can peak and run out much sooner than the presumed drug. The side effects of this drug are much more intense than for MDMA, and can include being stuck awake for multiple days, intense anxiety and agitation, overheating, seizure and in severe cases, death. This drug creates a strong urge to re-dose (take more), which can very quickly cause someone to take too much and overdose. If you choose to take this substance, we recommend taking a lower dose (e.g. 1/10th of the amount you might take of MDMA), not using alone, or combining it with other substances. If you experience any concerning symptoms, call 111 immediately and seek medical support.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: MDMA

Date brought in for testing: Last week of December

Substances detected in the sample: Alpha-D2PV, MDMA

This sample was adulterated with alpha-D2PV - a high-risk synthetic cathinone (also known as bath salts). MDMA was also detected in this sample. We cannot determine how much of each drug was in this mixture, but importantly - this sample would produce a false-positive reagent test for MDMA if checked at-home (dark purple masks the yellow cathinone colour change).

Alpha-D2PV may produce similar desirable effects as other stimulants, but can peak and run out much sooner than the presumed drug. The side effects of this drug are much more intense than for MDMA, and can include being stuck awake for multiple days, intense anxiety and agitation, overheating, seizure and in severe cases, death. This drug creates a strong urge to re-dose (take more), which can very quickly cause someone to take too much and overdose. If you choose to take this substance, we recommend taking a lower dose (e.g. 1/10th of the amount you might take of MDMA), not using alone, or combining it with other substances.

Combining more than one stimulant is more stressful for your body, and creates greater risk of negative side effects and overdose. If you experience any concerning symptoms, call 111 immediately and seek medical support.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: MDMA

Date brought in for testing: Last week of December

Substances detected in the sample: MDMA

This sample was consistent with the presence of MDMA only.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: Unknown

Date brought in for testing: Last week of December

Substances detected in the sample: Diazepam

This sample was found to contain Diazepam, a benzodiazepine drug often prescribed in pharmaceutical preparations for symptoms of anxiety. In high doses, or combined wiht other substances, this drug can produce side effects including drowsiness and amnesia. Importantly, other benzos (especially novel / illicit ones) taken in the previous few days / week can still be in someone's system days later, making it easy to overdose on another benzo. If you choose to take this substance, we recommend starting with a lower dose, and having trusted folks around who can make sure you're well and safe.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: MDMA, Ketamine, 2C-B

Date brought in for testing: Last week of December

Substances detected in the sample: MDMA, Ketamine, Caffeine

This sample was presumed to contain a common kiwi-style combination of substances - often confused by the similarity of the names "2C-B" (a psychedlic, 2-(4-bromo-2,5-dimethoxyphenyl)ethanamine) and "tucibi" ('pink cocaine').

No cocaine was detected in this sample. Although 2C-B was not detected, the small dose for 2C-B to have an effect (10-25 mg) means it may have been missed in this sample, and we recommend considering that 2C-B may still be present.

 

Ketamine is a dissociative anaesthetic which impacts your coordination, which you may be less aware of while under the influence of MDMA. Large doses of ketamine and MDMA together may create risk of Serotonin Syndrome, which can be fatal. Combining more than one stimulant is more stressful for your body, and creates greater risk of negative side effects and overdose.  We are unable to determine how much of each drug was in this sample.

Internationally, tucibi often contains additional potent psychoactives such as LSD, fentanyl, and other opioids. If you choose to take this substance, we recommend having naloxone on hand (and knowing how to use it), starting with a lower dose, having trusted folks around who can make sure you're well and safe, and limiting the maximum dose you might take. If you experience any concerning symptoms, call 111 immediately and seek medical support.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: MDMA

Date brought in for testing: Last week of December

Substances detected in the sample: Alpha-D2PV, MDMA, ketamine

This sample contained multiple drugs including alpha-D2PV - a high-risk synthetic cathinone (also known as bath salts). MDMA and ketamine were also detected in this sample. We cannot determine how much of each drug was in this mixture, but importantly - this sample would produce a false-positive reagent test for MDMA if checked at-home (dark purple masks the yellow cathinone colour change).

Ketamine is a dissociative anaesthetic which impacts your coordination, which you may be less aware of while under the influence of MDMA. Large doses of ketamine and MDMA together may create risk of Serotonin Syndrome, which can be fatal. Combining more than one stimulant is more stressful for your body, and creates greater risk of negative side effects and overdose.  We are unable to determine how much of each drug was in this sample.

If you choose to take this substance, we recommend having starting with a lower dose, having trusted folks around who can make sure you're well and safe, and limiting the maximum dose you might take. If you experience any concerning symptoms, call 111 immediately and seek medical support.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: Unknown

Date brought in for testing: Last week of December

Substances detected in the sample: Tadalafil (pink powder)

This sample was found to contain Tadalafil (a drug used in the erectile medication Cialis). This substance may not be as safe as pharmaceutical preparations of the drug. Additionally, we have seen similar samples containing this drug which also contained MDMA. If you choose to take this substance, consider that it could contain a psychoactive as well. We recommend having starting with a lower dose, having trusted folks around who can make sure you're well and safe, and limiting the maximum dose you might take to a therapeutic dose for tadalafil (e.g. 10 - 20 mg).

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: MDMA

Date brought in for testing: Last week of December

Substances detected in the sample: MDMA

This sample was consistent with the presence of MDMA only.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Older Samples

Substance presumed to be: MDMA

Date brought in for testing: 12th October, 2023 

Substances detected in the sample: MDMA 

Click here for more information on how to be safer when using MDMA.

Substance presumed to be: MDMA

Date brought in for testing: Last week of November

Substances detected in the sample: Dimethylpentylone

The only substance detected in this sample was Dimethylpentylone - a moderately risky synthetic cathinone (also known as bath salts). Dimethylpentylone may produce similar desirable effects as other stimulants, but can peak and run out much sooner than the presumed drug. The side effects of this drug are usually more intense than for MDMA, and can include being stuck awake for multiple days, and intense anxiety and agitation. This drug creates a strong urge to re-dose (take more), which can very quickly cause someone to take too much and overdose. If you choose to take this substance, we recommend taking a lower dose (e.g. 1/5th of the amount you might take of MDMA), not using alone, or combining it with other substances.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Substance presumed to be: Unknown

Date brought in for testing: Last week of November

Substances detected in the sample: Diclofenac (Voltaren)

This sample contained diclofenac, a non-steroidal anti-inflammatory drug. This substance is usually produced in pill format, dispensed in pharmacies. Unusual formats of drug may not be as safe to dose or take as pharmaceutical preparations. If you choose to take this substance, we recommend not taking more than 75 mg of this substance per day, and even better, obtaining a legitimate preparation from a medical professional.

Contact: NEST Drug Checking team drugchecking@nznep.org.nz or 0273150929

Share your feedback on the follow up testing process here. We want to provide you with useful information.

Call the New Zealand Drug Foundation if you want to anonymously talk through these results on (04) 801 6303.

 

Please note that some samples are still currently being tested.